Breaking News Instant updates and real-time market news.

XPO

XPO Logistics

$62.98

0.17 (0.27%)

08:12
01/14/19
01/14
08:12
01/14/19
08:12

XPO downgraded to Sector Weight at KeyBanc on European concerns, competition

As previously reported, KeyBanc analyst Todd Fowler downgraded XPO Logistics to Sector Weight from Overweight based on his view that the big and bulky final mile market is increasingly competitive, along with ongoing uncertainty around European end markets. While BBFM is only one element of the XPO story, it is often cited as a key differentiator, with competition from well-established, well-capitalized transport company's potentially slowing growth, and ongoing discord potentially impacting European growth, he adds.

  • 15

    Feb

XPO XPO Logistics
$62.98

0.17 (0.27%)

12/17/18
OPCO
12/17/18
NO CHANGE
Target $96
OPCO
Outperform
XPO Logistics price target cut to $96 from $114 at Oppenheimer
Oppenheimer analyst Scott Schneeburger reiterated an Outperform rating on XPO Logistics but cut his price target to $96 from $114, citing industry multiple contraction. In a research note to investors, Schneeburger says despite a tough run of negative sentiment, XPO's fundamental story remains little changed and he views XPO's recently introduced 12%-15% 2019 adjusted EBITDA growth guidance as achievable.
12/17/18
DBAB
12/17/18
NO CHANGE
DBAB
Buy
Deutsche says change reinforces view short seller not reflecting XPO prospects
Deutsche Bank analyst Amit Mehrotra noted that the short presentation on XPO Logistics that was published last week has been updated. The update appears to address several of the "basic calculation errors" the firm previously highlighted but, "more critically," it removes altogether certain aspects of its cash flow analysis, according to the analyst. The removal of an important point related to cash flow supports his initial conclusion that the report is not reflective of XPO's prospects, Mehrotra tells investors. He keeps a Buy rating on XPO Logistics shares.
01/02/19
DBAB
01/02/19
NO CHANGE
DBAB
Buy
Deutsche Bank analysis shows XPO short seller's calls hardly pan out
Shares of XPO Logistics recovered over 90% of the losses suffered following publication Spruce Point Management's short report on December 13, Deutsche Bank analyst Amit Mehrotra tells investors in a research note. The snap back is indicative of the short report being "riddled with inaccuracies and misleading statements," with no implications to the fundamental outlook for XPO shares, Mehrotra writes. The analyst's analysis of Spruce Point's over 30 short reports over the last four years shows that most of the firm's calls have not come to fruition. Further, almost two-thirds of companies targeted by the short seller have positive returns on a six-month basis, with an average return of up 19%, says Mehrotra. The analyst adds that while XPO's fundamentals are not immune to broader macro forces, he feels "strongly that the business model allows for more resilient cash flows than market participants appreciate." Mehrotra keeps a Buy rating on XPO Logistics and continues to call the company his top overall pick.
01/14/19
KEYB
01/14/19
DOWNGRADE
KEYB
Sector Weight
XPO Logistics downgraded to Sector Weight from Overweight at KeyBanc

TODAY'S FREE FLY STORIES

07:40
01/22/19
01/22
07:40
01/22/19
07:40
General news
Treasury Market Outlook: Treasury yields are lower in risk-off trades »

Treasury Market Outlook:…

TPC

Tutor Perini

$18.33

0.5 (2.80%)

07:39
01/22/19
01/22
07:39
01/22/19
07:39
Downgrade
Tutor Perini rating change  »

Tutor Perini downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBIO

Translate Bio

$5.53

-0.12 (-2.12%)

07:38
01/22/19
01/22
07:38
01/22/19
07:38
Hot Stocks
Translate Bio announces clinical hold on MRT5201 IND application from FDA »

Translate Bio announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSY

Insys Therapeutics

$4.42

-0.25 (-5.35%)

07:37
01/22/19
01/22
07:37
01/22/19
07:37
Initiation
Insys Therapeutics initiated  »

Insys Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCM

R1 RCM

$8.32

0.16 (1.96%)

07:37
01/22/19
01/22
07:37
01/22/19
07:37
Initiation
R1 RCM initiated  »

R1 RCM initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$49.23

0.76 (1.57%)

07:36
01/22/19
01/22
07:36
01/22/19
07:36
Recommendations
Intel analyst commentary  »

Intel Q4 results should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 24

    Jan

  • 25

    Feb

  • 25

    Mar

  • 26

    Mar

ONCS

OncoSec

$0.71

0.0134 (1.93%)

07:35
01/22/19
01/22
07:35
01/22/19
07:35
Conference/Events
OncoSec management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

D

Dominion

$68.75

-0.15 (-0.22%)

07:35
01/22/19
01/22
07:35
01/22/19
07:35
Downgrade
Dominion rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 10

    Feb

UBSH

Union Bankshares

$32.50

0.14 (0.43%)

07:35
01/22/19
01/22
07:35
01/22/19
07:35
Earnings
Union Bankshares reports Q4 ex-items EPS 70c, consensus 68c »

Q4 net charge-offs were…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 11

    Feb

JD

JD.com

$23.25

1.12 (5.06%)

, INTC

Intel

$49.23

0.76 (1.57%)

07:35
01/22/19
01/22
07:35
01/22/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

JD

JD.com

$23.25

1.12 (5.06%)

INTC

Intel

$49.23

0.76 (1.57%)

WYNN

Wynn Resorts

$115.19

0.94 (0.82%)

NKE

Nike

$80.45

1.33 (1.68%)

CRON

Cronos Group

$14.89

1.25 (9.16%)

MGM

MGM Resorts

$28.55

0.83 (2.99%)

AUY

Yamana Gold

$2.31

-0.12 (-4.94%)

UAA

Under Armour

$20.50

0.47 (2.35%)

I

Intelsat

$21.15

-1.26 (-5.62%)

APC

Anadarko

$48.68

0.61 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 24

    Jan

  • 06

    Feb

  • 10

    Feb

  • 13

    Feb

  • 21

    Feb

  • 25

    Feb

  • 25

    Mar

  • 26

    Mar

INCY

Incyte

$78.44

-0.22 (-0.28%)

07:34
01/22/19
01/22
07:34
01/22/19
07:34
Hot Stocks
Incyte treats first patient in Phase 3 clinical trial of itacitinib »

Incyte Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

AMBR

Amber Road

$8.45

0.19 (2.30%)

07:34
01/22/19
01/22
07:34
01/22/19
07:34
Hot Stocks
Amber Road confirms receipt of director nominations from Altai Capital »

Amber Road confirmed that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Jan

  • 11

    Feb

CORV

Correvio

$3.24

0.365 (12.70%)

07:34
01/22/19
01/22
07:34
01/22/19
07:34
Recommendations
Correvio analyst commentary  »

Correvio to unlock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBSV

ObsEva

$13.72

0.22 (1.63%)

07:33
01/22/19
01/22
07:33
01/22/19
07:33
Conference/Events
ObsEva management to meet with Leerink »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

TGP

Teekay LNG

$12.80

0.23 (1.83%)

07:33
01/22/19
01/22
07:33
01/22/19
07:33
Upgrade
Teekay LNG rating change  »

Teekay LNG upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CABO

Cable One

$850.40

8.96 (1.06%)

07:32
01/22/19
01/22
07:32
01/22/19
07:32
Upgrade
Cable One rating change  »

Cable One upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRDCY

Bridgestone

$0.00

(0.00%)

07:32
01/22/19
01/22
07:32
01/22/19
07:32
Downgrade
Bridgestone rating change  »

Bridgestone downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCN

Neovasc

$0.75

0.0001 (0.01%)

, EW

Edwards Lifesciences

$168.41

9.29 (5.84%)

07:31
01/22/19
01/22
07:31
01/22/19
07:31
Hot Stocks
Neovasc announces dismissal of claim brought by Edwards Lifesciences »

Neovasc (NVCN) announced…

NVCN

Neovasc

$0.75

0.0001 (0.01%)

EW

Edwards Lifesciences

$168.41

9.29 (5.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 31

    Jan

STT

State Street

07:30
01/22/19
01/22
07:30
01/22/19
07:30
Downgrade
State Street rating change  »

State Street downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WERN

Werner

, KNX

Knight-Swift

$32.69

1.005 (3.17%)

07:30
01/22/19
01/22
07:30
01/22/19
07:30
Recommendations
Werner, Knight-Swift analyst commentary  »

Deutsche Bank names…

WERN

Werner

KNX

Knight-Swift

$32.69

1.005 (3.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Apr

PANW

Palo Alto Networks

$203.29

0.06 (0.03%)

, FTNT

Fortinet

$70.50

-2.1 (-2.89%)

07:30
01/22/19
01/22
07:30
01/22/19
07:30
Upgrade
Palo Alto Networks, Fortinet rating change  »

Palo Alto Networks…

PANW

Palo Alto Networks

$203.29

0.06 (0.03%)

FTNT

Fortinet

$70.50

-2.1 (-2.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 06

    Feb

  • 25

    Feb

AIG

AIG

$44.15

0.86 (1.99%)

07:27
01/22/19
01/22
07:27
01/22/19
07:27
Recommendations
AIG analyst commentary  »

Deutsche Bank closes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMU

Immunomedics

$13.31

-4.75 (-26.30%)

07:25
01/22/19
01/22
07:25
01/22/19
07:25
Downgrade
Immunomedics rating change  »

Immunomedics downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRO

GoPro

$4.92

0.015 (0.31%)

07:25
01/22/19
01/22
07:25
01/22/19
07:25
Recommendations
GoPro analyst commentary  »

GoPro still…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 25

    Feb

07:25
01/22/19
01/22
07:25
01/22/19
07:25
General news
FX Update »

FX Update: A generally…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.